Table 1. Demographic and baseline characteristics of the sample.
| Placebo taping (n = 31) | Kinesio taping (n = 30) | |
|---|---|---|
| Age (years) | 48.87 (9.09) | 49.47 (11.15) |
| Sex (female) | 17 (54.8%) | 17 (56.6%) |
| Weight (kg) | 76.21 (16.13) | 80.95 (17.19) |
| Height (m) | 1.67 (0.08) | 1.68 (0.10) |
| BMI (kg/m2) | 25.75 (5.87) | 27.59 (4.34) |
| Evolution time (months) | 36 (96) | 36 (49) |
| Employment status | ||
| Actively employed | 12 (38.71%) | 14 (46.67%) |
| Incapacitated (temporary) | 0 (0%) | 3 (10.00%) |
| Incapacitated (permanent) | 1 (3.22%) | 2 (6.67%) |
| Unemployed (health reasons) | 2 (6.45%) | 0 (0%) |
| Unemployed (other) | 9 (29.03%) | 6 (20.00%) |
| Student | 0 (0%) | 1 (3.33%) |
| Homemaker | 6 (19.35%) | 3 (10.00%) |
| Retired | 1 (3.22%) | 1 (3.33%) |
| Charlson Comorbidity Index | 1.50 (1.54) | 1.28 (1.66) |
| Pre-treatment values | ||
| RMDQ | 8.39 (4.28) | 10.20 (4.05) |
| NPRS | 5.93 (1.73) | 6.80 (2.26) |
| EQ-index | 0.59 (0.21) | 0.60 (1.89) |
| EQ-VAS | 57.50 (18.23) | 59.67 (18.61) |
Values presented as the mean (SD) or n (%).